Rihoux JP |
The inhibiting effect of cetirizine 2 HC1 on eosinophil migration and its link to H1 blockade. |
1991 |
Agents Actions Suppl. |
pmid:1675836
|
Kurosawa M |
Effect of platelet activating factor on histamine release from rat mast cells. |
1987 |
Agents Actions Suppl. |
pmid:2445185
|
Page CP et al. |
Drugs affecting pulmonary responses to platelet activating factor as novel anti-asthma drugs. |
1988 |
Agents Actions Suppl. |
pmid:3051932
|
Muirhead EE |
Vasodepressor lipid of the renomedullary interstitial cells of the renal papilla is a prohormone activated by the liver. |
1987 |
Agents Actions Suppl. |
pmid:3324720
|
Etienne A et al. |
Antithrombotic activity of BN 50341, a structurally new compound with anticalcic and PAF-antagonistic properties. |
1986 |
Agents Actions Suppl. |
pmid:3468781
|
|
PAF, platelets and asthma. Proceedings of a meeting. September 7-9, 1986. |
1987 |
Agents Actions Suppl. |
pmid:3478993
|
Farr RS et al. |
Platelet abnormalities in asthma--do they exist in humans? |
1987 |
Agents Actions Suppl. |
pmid:3478994
|
Menz G et al. |
Lack of PAF release in extrinsic asthma. |
1987 |
Agents Actions Suppl. |
pmid:3478995
|
Szczeklik A et al. |
Bleeding time and PAF-acether-induced platelet aggregation in atopy. |
1987 |
Agents Actions Suppl. |
pmid:3478996
|
Schmitz-Schumann M et al. |
Evidence of PAF release and platelet activation in analgesics-asthma-syndrome. |
1987 |
Agents Actions Suppl. |
pmid:3478999
|
Guinot P et al. |
Effects of BN 52063 on PAF-acether induced weal and flare in man. |
1987 |
Agents Actions Suppl. |
pmid:3479000
|
Lang M et al. |
Effects of the PAF-antagonist CV-3988 on PAF-induced changes in mucus secretion and in respiratory and circulatory variables in ferrets. |
1987 |
Agents Actions Suppl. |
pmid:3479001
|
Barnes PJ |
New concepts in the pathogenesis of bronchial hyperresponsiveness. |
1987 |
Agents Actions Suppl. |
pmid:3314413
|
Mustard JF et al. |
Platelet activation--an overview. |
1987 |
Agents Actions Suppl. |
pmid:3314414
|
Page CP and Robertson DN |
Properties of PAF relevant to asthma. |
1987 |
Agents Actions Suppl. |
pmid:3314416
|
Morley J |
PAF and airway hyperreactivity; prospects for novel prophylactic anti-asthma drugs. |
1987 |
Agents Actions Suppl. |
pmid:3314417
|
Braquet P et al. |
The role of PAF-acether in anaphylaxis demonstrated with the use of the antagonist BN 52021. |
1987 |
Agents Actions Suppl. |
pmid:3314418
|
Anderson GP and Fennessy MR |
Lipoxygenase metabolites as mediators of platelet activating factor-induced increased airways responsiveness to histamine in the guinea-pig. |
1988 |
Agents Actions Suppl. |
pmid:3140616
|
Schrör K and Felsch A |
Ramiprilat prevents PAF-induced myocellular and endothelial injury in a neutrophil-perfused heart preparation. |
1992 |
Agents Actions Suppl. |
pmid:1334351
|
Stenzel H et al. |
Effect of the PAF-antagonist SRI 63-441 on the allergic reaction in awake dogs with natural asthma. |
1987 |
Agents Actions Suppl. |
pmid:2823582
|
O'Flaherty JT and Wykle RL |
Metabolic origin and fate of platelet-activating factor. |
1987 |
Agents Actions Suppl. |
pmid:2823583
|
Bertrand C et al. |
Selective implication of thromboxane A2 and PAF-acether in two guinea pig anaphylactic models. |
1990 |
Agents Actions Suppl. |
pmid:2080755
|
Tsunoda H et al. |
Effects of a novel PAF antagonist, E6123, on PAF-induced biological responses. |
1990 |
Agents Actions Suppl. |
pmid:2080757
|
Sakuma Y et al. |
Effects of a novel PAF antagonist, E6123, on passive anaphylaxis. |
1990 |
Agents Actions Suppl. |
pmid:2080758
|
Soloviev A and Braquet P |
The similarity in action of hypoxia and platelet-activating factor on smooth muscle cells of coronary arteries: possible explanation for hypoxic coronary spasm development. |
1995 |
Agents Actions Suppl. |
pmid:7717190
|
Bult H et al. |
Complement derived factors and prostacyclin formation by rabbit isolated peritoneum and cultured mesothelial cells. |
1984 |
Agents Actions Suppl. |
pmid:6382974
|
Parnham MJ et al. |
Regulation of the oxidative burst of macrophages by lipid mediators. |
1984 |
Agents Actions Suppl. |
pmid:6433680
|
Vargaftig BB |
Phospholipids, particularly platelet-activating factor (PAF-acether), in experimental bronchoconstriction. |
1983 |
Agents Actions Suppl. |
pmid:6575594
|
Page CP et al. |
PAF-acether: a putative mediator of asthma and inflammation. |
1983 |
Agents Actions Suppl. |
pmid:6575595
|
Madi S et al. |
Allergen-induced bronchospasm in passively sensitized guinea pigs: influence of new substances in comparison to reference compounds. |
1991 |
Agents Actions |
pmid:2058463
|
Braquet P and Esanu A |
New trends in PAF antagonist research: a new series of potent hetrapazine-derived PAF antagonists. |
1991 |
Agents Actions |
pmid:2058466
|
Northover AM |
Modification by some antagonists of the shape changes of venous endothelial cells in response to inflammatory agents in vitro. |
1990 |
Agents Actions |
pmid:2111079
|
Will PC et al. |
Platelet activating factor as a proinflammatory mediator in acetic-induced colitis in the rat. |
1991 |
Agents Actions |
pmid:1793026
|
Vincent D et al. |
Dissociation between LPS-induced bronchial hyperreactivity and airway edema in the guinea-pig. |
1991 |
Agents Actions |
pmid:1793031
|
Desai S and Barton R |
Role of platelet activating factor in the pathogenesis of active and passive models of experimental allergic encephalomyelitis in the rat. |
1990 |
Agents Actions |
pmid:2285021
|
Trebien HA and Calixto JB |
Pharmacological evaluation of rat paw oedema induced by Bothrops jararaca venom. |
1989 |
Agents Actions |
pmid:2660497
|
Howat DW et al. |
An investigation into the possible involvement of platelet activating factor in experimental allergic encephalomyelitis in rats. |
1989 |
Agents Actions |
pmid:2801340
|
Appleby P and Bowen JG |
Cutaneous inflammatory disorders. |
1990 |
Agents Actions |
pmid:2117335
|
Lundgren JD et al. |
Platelet activating factor and tracheobronchial respiratory glycoconjugate release in feline and human explants: involvement of the lipoxygenase pathway. |
1990 |
Agents Actions |
pmid:2117336
|
Doyle SA et al. |
Further studies on the antinociceptive effects of delta 6-THC-7-oic acid. |
1990 |
Agents Actions |
pmid:2178317
|
Nieminen MM et al. |
Body temperature modulates the effect of platelet-activating factor (PAF) on airways responsiveness in the rabbit. |
1991 |
Agents Actions |
pmid:1862740
|
Swingle KF and Reiter MJ |
Inhibition of Paf-acether-induced edema of the rat's paw. |
1986 |
Agents Actions |
pmid:2875631
|
Flower RJ |
Background and discovery of lipocortins. |
1986 |
Agents Actions |
pmid:2938452
|
Adnot S et al. |
Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets. |
1987 |
Agents Actions |
pmid:3115070
|
Montrucchio G et al. |
The pattern of cardiovascular alterations induced by infusion of platelet-activating factor in rabbit is modified by pretreatment with H1-H2 receptor antagonists but not by cyclooxygenase inhibition. |
1987 |
Agents Actions |
pmid:3115072
|
Morley J |
Platelet activating factor and asthma. |
1986 |
Agents Actions |
pmid:3099555
|
Cahill M et al. |
Effect of des arginine9-bradykinin and other bradykinin fragments on the synthesis of prostacyclin and the binding of bradykinin by vascular cells in culture. |
1988 |
Agents Actions |
pmid:3051930
|
Cunha FQ et al. |
Failure of PAF-acether to induce in vivo neutrophil migration. |
1988 |
Agents Actions |
pmid:3055873
|
Ramesha CS et al. |
Identification and quantitation of PAF from psoriatic scales. |
1987 |
Agents Actions |
pmid:3687590
|
Friedlander G et al. |
Renal effects of platelet-activating factor in the rat. |
1987 |
Agents Actions |
pmid:3687594
|
Touvay C et al. |
Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba. |
1986 |
Agents Actions |
pmid:3754380
|
Lauri D et al. |
Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin. |
1986 |
Agents Actions |
pmid:3706054
|
Etienne A et al. |
In vivo inhibition of plasma protein leakage and Salmonella enteritidis-induced mortality in the rat by a specific paf-acether antagonist: BN 52021. |
1986 |
Agents Actions |
pmid:3515870
|
Mastacchi R et al. |
Interaction of a new low molecular weight heparin (OP/LMWH) with human platelets. |
1986 |
Agents Actions |
pmid:3518359
|
Pettipher ER et al. |
PAF-acether in chronic arthritis. |
1987 |
Agents Actions |
pmid:3630862
|
Archer CB et al. |
Actions of disodium cromoglycate (DSCG) on human skin responses to histamine, codeine and Paf-acether. |
1985 |
Agents Actions |
pmid:3923788
|
Parente L et al. |
The effect of glucocorticoids on lyso-PAF formation in vitro and in vivo. |
1986 |
Agents Actions |
pmid:3962774
|
Tarayre JP et al. |
Inflammatory action of PAF-acether in the rat pleural cavity. |
1986 |
Agents Actions |
pmid:3962789
|
Pirotzky E et al. |
Vascular permeability induced by Paf-acether (platelet-activating factor) in the isolated perfused rat kidney. |
1985 |
Agents Actions |
pmid:4003192
|
Page CP et al. |
Platelet activating factor (Paf-acether) may account for late-onset reactions to allergen inhalation. |
1985 |
Agents Actions |
pmid:4003195
|
Page CP et al. |
Suppression of Paf-acether responses: an anti-inflammatory effect of anti-asthma drugs. |
1985 |
Agents Actions |
pmid:4003196
|
Spicer BA et al. |
An investigation of the involvement of platelet activating factor in the non-histamine immediate hypersensitivity reaction in the rat peritoneal cavity. |
1985 |
Agents Actions |
pmid:4003197
|
Boughton-Smith NK et al. |
Actions of nitric oxide on the acute gastrointestinal damage induced by PAF in the rat. |
1992 |
Agents Actions |
pmid:1279960
|
Perales J et al. |
Neutralization of the oedematogenic activity of Bothrops jararaca venom on the mouse paw by an antibothropic fraction isolated from opossum (Didelphis marsupialis) serum. |
1992 |
Agents Actions |
pmid:1295374
|
Wong CW et al. |
Comparative effects of tetrandrine and berbamine on subcutaneous air pouch inflammation induced by interleukin-1, tumour necrosis factor and platelet-activating factor. |
1992 |
Agents Actions |
pmid:1414679
|
Tran A et al. |
Separate induction of human blood platelet aggregation or cytotoxicity by different concentrations of PAF-acether and thrombin. |
1992 |
Agents Actions |
pmid:1414687
|
Okamoto H et al. |
Suppression of the Arthus reaction by Y-24180, a potent and specific antagonist of platelet-activating factor. |
1992 |
Agents Actions |
pmid:1388318
|
Miyagawa H et al. |
The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils. |
1992 |
Agents Actions |
pmid:1456179
|
Rachmilewitz D et al. |
Cytokines and platelet-activating factor in human inflamed colonic mucosa. |
1992 |
Agents Actions |
pmid:1359744
|
Ogunbiyi PO and Eyre P |
Pharmacological studies of pulmonary anaphylaxis in vitro: a review. |
1985 |
Agents Actions |
pmid:2420161
|
Lewis AJ et al. |
The effects of antiallergic and bronchodilator drugs on platelet-activating factor (PAF-acether) induced bronchospasm and platelet aggregation. |
1984 |
Agents Actions |
pmid:6152379
|
Tubaro E et al. |
In vitro and in vivo impact of a new glycosphingolipid on neutrophils. |
1994 |
Agents Actions |
pmid:7879694
|
Canale P et al. |
TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock. |
1994 |
Agents Actions |
pmid:7879698
|
Raff GW et al. |
Procoagulant property of platelet activating factor (PAF). |
1993 |
Agents Actions |
pmid:8273543
|
Meats JE et al. |
Identification of phospholipase D (PLD) activity in mouse peritoneal macrophages. |
1993 |
Agents Actions |
pmid:8273553
|
Thomas TK et al. |
Differential antagonism of platelet activating factor-induced neutrophilia and gastric hemorrhage in the rat. |
1993 |
Agents Actions |
pmid:8273566
|
Kantar A et al. |
Effect of PAF on human lymphocyte membranes: a fluorescence study. |
1993 |
Agents Actions |
pmid:8317302
|
Boonen GJ et al. |
Activation of neutrophil migration by dioctanoyl-sn-glycerol and fMet-Leu-Phe is controlled by different pathways. |
1993 |
Agents Actions |
pmid:8317308
|
Murphy G |
Report of the 14th meeting of the British Inflammation Research Association. Topic: cellular and molecular aspects of inflammatory bowel disease. |
1993 |
Agents Actions |
pmid:8480529
|
Sakamoto T et al. |
Effect of beta 2-adrenoceptor agonists against platelet-activating factor-induced airway microvascular leakage and bronchoconstriction in the guinea pig. |
1993 |
Agents Actions |
pmid:7908496
|
Perret BA et al. |
Binding of bovine factor VIII-coated colloidal gold particles to receptors on platelet membranes. |
1981 |
Agents Actions |
pmid:6803540
|
Denburg JA et al. |
Platelet activating factor: regulation by mast cells and aspirin. |
1984 |
Agents Actions |
pmid:6711391
|
Jouvin-Marche E et al. |
Platelet-activating factor (PAF-acether), an activator of neutrophil functions. |
1982 |
Agents Actions |
pmid:6299078
|
Caillard CG et al. |
Hypotensive activity of PAF-acether in rats. |
1982 |
Agents Actions |
pmid:6299079
|
Mencia-Huerta JM et al. |
Is platelet-activating factor (PAF-acether) synthesis by murine peritoneal cells (PC) a two-step process? |
1981 |
Agents Actions |
pmid:7053072
|
Vargaftig BB |
Platelet-activating factor (PAF-acether) |
1982 |
Agents Actions |
pmid:7164939
|
Bette P and Bienvenue A |
Exchange of a spin-labeled analog of PAF-acether between micelles, serum albumin and model membranes. |
1982 |
Agents Actions |
pmid:7164940
|
Lartigue-Mattei C et al. |
Pharmacokinetic study of PAF-acether. Preliminary results after the intravenous administration of a 3H-labelled product to the rabbit. |
1982 |
Agents Actions |
pmid:7164941
|
Morgat JL et al. |
Radio-labelling of 1-O-alkyl, 2-O-acetyl, sn-glycero-3-phosphorylcholine, 1-O-(9,10-di3H)-octadecyl PAF-acether. |
1982 |
Agents Actions |
pmid:7164942
|
Convert O et al. |
1H NMR of PAF-acether: influence of solvent on its structure. |
1982 |
Agents Actions |
pmid:7164943
|
Borrel MC et al. |
Additional techniques for the total synthesis of PAF-acether. |
1982 |
Agents Actions |
pmid:7164944
|
Benveniste J et al. |
Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types. |
1982 |
Agents Actions |
pmid:7164945
|
Arnoux B et al. |
Release of PAF-acether from human blood monocytes. |
1982 |
Agents Actions |
pmid:7164946
|
Fouque F et al. |
Platelet-activating factor (PAF-acether): thromboxane-independent synergism with adrenaline on human platelets and recent insights into its mode of action. |
1982 |
Agents Actions |
pmid:7164947
|
Vargaftig BB et al. |
Platelet-tissue interaction: role of platelet-activating factor (PAF-acether). |
1980 |
Agents Actions |
pmid:7270336
|
Bonnet J et al. |
Platelet-activating factor acether (PAF-acether) involvement in acute inflammatory and pain processes. |
1981 |
Agents Actions |
pmid:7340441
|
Heller R et al. |
S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells. |
1993 |
Agents Actions |
pmid:7517616
|
Louis R et al. |
Potentiation of histamine release from human leucocytes by PAF. |
1994 |
Agents Actions |
pmid:7521570
|
Camussi G et al. |
Neutropenia induced by platelet-activating factor (PAF-acether) released from neutrophils: the inhibitory effect of prostacyclin (PGI2). |
1981 |
Agents Actions |
pmid:7041569
|
Northover AM and Northover BJ |
Involvement of protein kinase C in the control of microvascular permeability to colloidal carbon. |
1993 |
Agents Actions |
pmid:8304240
|